Skip to main content
Erschienen in: Lung 4/2010

01.08.2010

Improving Heart Rate Variability in Sleep Apnea Patients: Differences in Treatment with Auto-titrating Positive Airway Pressure (APAP) Versus Conventional CPAP

verfasst von: Levent Karasulu, Pınar Özkan Epöztürk, Sinem Nedime Sökücü, Levent Dalar, Sedat Altın

Erschienen in: Lung | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

The effect of positive airway pressure treatments in different modalities on the cardiovascular consequences of the disease in sleep apnea patients is still unclear. We aimed to compare auto-titrating positive airway pressure (APAP) and conventional continuous positive airway pressure (CPAP) in terms of improving heart rate variability (HRV) in obstructive sleep apnea patients. This was a prospective study done in a tertiary research hospital. All patients underwent a manual CPAP titration procedure to determine the optimal pressure that abolishes abnormal respiratory events. Then patients underwent two treatment nights, one under APAP mode and one under conventional CPAP mode with a 1-week interval. Forty newly diagnosed obstructive sleep apnea patients were enrolled in the study. We compared heart rate variability analysis parameters between the APAP night and the CPAP night. This final analysis included the data of 28 patients (M/F: 22/6; mean age = 46 ± 10 years). Sleep characteristics were comparable between the two treatment nights, whereas all-night time domains of HRV analysis such as HF, nuLF, and LF/HF were different between APAP and CPAP nights (2.93 ± 0.31 vs. 3.01 ± 0.31; P = 0.041; 0.75 ± 0.13 vs. 0.71 ± 0.14; P = 0.027; and 4.37 ± 3.24 vs. 3.56 ± 2.07; P = 0.023, respectively). HRV analysis for individual sleep stages showed that Stage 2 LF, nuLF, nuHF, LF/HF parameters entirely improved under CPAP treatment whereas APAP treatment resulted in nonsignificant changes. These results suggest that despite comparable improvement in abnormal respiratory events with APAP or CPAP treatments, CPAP may be superior to APAP in terms of correcting cardiovascular alterations in sleep apnea patients.
Literatur
1.
Zurück zum Zitat Golbin JM, Somers VK, Caples SM (2008) Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thorac Soc 5:200–206CrossRefPubMed Golbin JM, Somers VK, Caples SM (2008) Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thorac Soc 5:200–206CrossRefPubMed
2.
Zurück zum Zitat Sullivan CE, Issa FG, Berthon-Jones M, Eves L (1981) Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1:862–865CrossRefPubMed Sullivan CE, Issa FG, Berthon-Jones M, Eves L (1981) Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1:862–865CrossRefPubMed
3.
Zurück zum Zitat Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering T, Russel R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in Collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). J Am Coll Cardiol 52:686–717CrossRefPubMed Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering T, Russel R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in Collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). J Am Coll Cardiol 52:686–717CrossRefPubMed
4.
Zurück zum Zitat Guilleminault C, Poyares D, Rosa A, Huang Y (2005) Heart rate variability, sympathetic and vagal balance and EEG arousals in upper airway resistance and mild obstructive sleep apnea syndromes. Sleep Med 6:451–457CrossRefPubMed Guilleminault C, Poyares D, Rosa A, Huang Y (2005) Heart rate variability, sympathetic and vagal balance and EEG arousals in upper airway resistance and mild obstructive sleep apnea syndromes. Sleep Med 6:451–457CrossRefPubMed
5.
Zurück zum Zitat Chaicharn J, Carrington M, Trinder J, Khoo MCK (2008) The effects on cardiovascular autonomic control of repetitive arousal from sleep. Sleep 31:93–103PubMed Chaicharn J, Carrington M, Trinder J, Khoo MCK (2008) The effects on cardiovascular autonomic control of repetitive arousal from sleep. Sleep 31:93–103PubMed
6.
Zurück zum Zitat Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J (1995) The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18:377–381PubMed Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J (1995) The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18:377–381PubMed
7.
Zurück zum Zitat Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K (1995) Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8:222–229CrossRefPubMed Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K (1995) Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8:222–229CrossRefPubMed
8.
Zurück zum Zitat Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK (1999) Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100:2332–2335PubMed Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK (1999) Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100:2332–2335PubMed
9.
Zurück zum Zitat Konermann M, Sanner BM, Vyleta M, Laschewski F, Groetz J, Sturm A, Zidek W (1998) Use of conventional and self-adjusting nasal continuous positive airway pressure for treatment of severe obstructive sleep apnea syndrome: a comparative study. Chest 113:714–718CrossRefPubMed Konermann M, Sanner BM, Vyleta M, Laschewski F, Groetz J, Sturm A, Zidek W (1998) Use of conventional and self-adjusting nasal continuous positive airway pressure for treatment of severe obstructive sleep apnea syndrome: a comparative study. Chest 113:714–718CrossRefPubMed
10.
Zurück zum Zitat Nussbaumer Y, Bloch KE, Genser T, Thurnheer R (2006) Equivalence of autoadjusted and constant continuous positive airway pressure in home treatment of sleep apnea. Chest 129:638–643CrossRefPubMed Nussbaumer Y, Bloch KE, Genser T, Thurnheer R (2006) Equivalence of autoadjusted and constant continuous positive airway pressure in home treatment of sleep apnea. Chest 129:638–643CrossRefPubMed
11.
Zurück zum Zitat Dursunoğlu N, Dursunoğlu D, Cuhadaroğlu C, Kiliçaslan Z (2005) Acute effects of automated continuous positive airway pressure on blood pressure in patients with sleep apnea and hypertension. Respiration 72:150–155CrossRefPubMed Dursunoğlu N, Dursunoğlu D, Cuhadaroğlu C, Kiliçaslan Z (2005) Acute effects of automated continuous positive airway pressure on blood pressure in patients with sleep apnea and hypertension. Respiration 72:150–155CrossRefPubMed
12.
Zurück zum Zitat Patruno V, Aiolfi S, Costantino G, Murgia R, Selmi C, Maliani A, Montano N (2007) Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 131:1393–1399CrossRefPubMed Patruno V, Aiolfi S, Costantino G, Murgia R, Selmi C, Maliani A, Montano N (2007) Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 131:1393–1399CrossRefPubMed
13.
Zurück zum Zitat Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK (1998) Altered cardiovascular variability in obstructive sleep apnea. Circulation 98:1071–1077PubMed Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK (1998) Altered cardiovascular variability in obstructive sleep apnea. Circulation 98:1071–1077PubMed
14.
Zurück zum Zitat Narkiewicz K, Somers VK (2001) Cardiovascular variability characteristics in obstructive sleep apnea. Auton Neurosci 90:89–94CrossRefPubMed Narkiewicz K, Somers VK (2001) Cardiovascular variability characteristics in obstructive sleep apnea. Auton Neurosci 90:89–94CrossRefPubMed
15.
Zurück zum Zitat Gula LJ, Krahn AD, Skanes A, Ferguson KA, George C, Yee R, Klein G (2003) Heart rate variability in obstructive sleep apnea: a prospective study and frequency domain analysis. Ann Noninvasive Electrocardiol 8:144–149CrossRefPubMed Gula LJ, Krahn AD, Skanes A, Ferguson KA, George C, Yee R, Klein G (2003) Heart rate variability in obstructive sleep apnea: a prospective study and frequency domain analysis. Ann Noninvasive Electrocardiol 8:144–149CrossRefPubMed
16.
Zurück zum Zitat Maser RE, Lenhard MJ, Rizzo AA, Vasile AA (2008) Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. Chest 133:86–91CrossRefPubMed Maser RE, Lenhard MJ, Rizzo AA, Vasile AA (2008) Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. Chest 133:86–91CrossRefPubMed
17.
Zurück zum Zitat Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065
18.
Zurück zum Zitat Bonnet MH, Arand DL (1997) Heart rate variability: sleep stage, time of night, and arousal influences. Electroencephalogr Clin Neurophysiol 102:390–396CrossRefPubMed Bonnet MH, Arand DL (1997) Heart rate variability: sleep stage, time of night, and arousal influences. Electroencephalogr Clin Neurophysiol 102:390–396CrossRefPubMed
19.
Zurück zum Zitat Yasuma F, Hayano J (2004) Respiratory sinus arrhythmia: why does the heartbeat synchronize with respiratory rhythm? Chest 125:683–690CrossRefPubMed Yasuma F, Hayano J (2004) Respiratory sinus arrhythmia: why does the heartbeat synchronize with respiratory rhythm? Chest 125:683–690CrossRefPubMed
20.
Zurück zum Zitat O’Donnell CP, Allan L, Atkinson P, Schwartz AR (2002) The effect of upper airway obstruction and arousal on peripheral arterial tonometry in obstructive sleep apnea. Am J Respir Crit Care Med 166:965–971CrossRefPubMed O’Donnell CP, Allan L, Atkinson P, Schwartz AR (2002) The effect of upper airway obstruction and arousal on peripheral arterial tonometry in obstructive sleep apnea. Am J Respir Crit Care Med 166:965–971CrossRefPubMed
21.
Zurück zum Zitat Sforza E, Jouny C, Ibanez V (2000) Cardiac activation during arousal in humans: further evidence for hierarchy in the arousal response. Clin Neurophysiol 111:1611–1619CrossRefPubMed Sforza E, Jouny C, Ibanez V (2000) Cardiac activation during arousal in humans: further evidence for hierarchy in the arousal response. Clin Neurophysiol 111:1611–1619CrossRefPubMed
22.
Zurück zum Zitat Krieger J, Schröder C, Erhardt C (2003) Cortical arousal, autonomic arousal. Evaluation techniques and clinical importance. Rev Neurol (Paris) 159(11 Suppl):6S107–6S112 Krieger J, Schröder C, Erhardt C (2003) Cortical arousal, autonomic arousal. Evaluation techniques and clinical importance. Rev Neurol (Paris) 159(11 Suppl):6S107–6S112
23.
Zurück zum Zitat Harsch IA, Schahin SP, Radespiel-Tröger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162CrossRefPubMed Harsch IA, Schahin SP, Radespiel-Tröger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162CrossRefPubMed
24.
Zurück zum Zitat Shamsuzzaman ASM, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:1906–1914CrossRefPubMed Shamsuzzaman ASM, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:1906–1914CrossRefPubMed
Metadaten
Titel
Improving Heart Rate Variability in Sleep Apnea Patients: Differences in Treatment with Auto-titrating Positive Airway Pressure (APAP) Versus Conventional CPAP
verfasst von
Levent Karasulu
Pınar Özkan Epöztürk
Sinem Nedime Sökücü
Levent Dalar
Sedat Altın
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 4/2010
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9237-4

Weitere Artikel der Ausgabe 4/2010

Lung 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.